ReviewMolecular biology reports2026
Carbonic anhydrase VIII as a regulator of intracellular calcium signaling: mechanistic insights and implications in human disease.
Review in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Unveiling Carbonic Anhydrase VIII, X, XI Expression in Cancer and Neurological Diseases Through Integrated Bioinformatics Approaches.Bioinformatics and biology insights · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Carbonic anhydrases are classically defined as zinc-dependent enzymes that catalyze the reversible hydration of carbon dioxide and play essential roles in acid-base homeostasis. However, carbonic anhydrase VIII (CA VIII) represents a catalytically inactive member of this family due to the absence of one of the three histidine residues required for enzymatic activityStructural analyses further indicate that, despite this loss of catalytic function, CA VIII retains the conserved carbonic anhydrase fold, suggesting functional repurposing rather than structural degeneration. Despite this catalytic silencing, CA VIII is evolutionarily conserved and highly expressed in neuronal tissues, indicating important biological functions beyond enzymatic catalysis. Converging structural, biochemical, and genetic evidence supports the view that CA VIII functions as a pseudoenzyme that regulates intracellular signaling pathways. Mechanistically, CA VIII interacts with the inositol 1,4,5-trisphosphate receptor type 1 (IP3R1), modulating intracellular calcium release and thereby influencing neuronal excitability, synaptic function, and cerebellar development. Disruption of CA VIII has been consistently associated with altered calcium homeostasis and impaired neuronal signaling. Importantly, human genetic studies provide direct evidence for the physiological significance of CA VIII. Mutations identified in affected families, including reports from Iraqi and Saudi Arabian populations, are associated with cerebellar ataxia and neurodevelopmental abnormalities, linking CA VIII dysfunction to human disease. These findings establish CA VIII as a critical regulator of neuronal calcium signaling with clear clinical relevance. In this review, we integrate structural, molecular, and genetic evidence to position CA VIII as a functionally repurposed pseudoenzyme that operates as a signaling regulator rather than a catalytic enzyme. We further discuss its emerging roles in neuronal physiology and disease, and highlight broader implications for pseudoenzyme biology and the evolution of protein function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.